Professor, Internal Medicine, Rush Medical College of Rush Univ
Hematology
Dr. Sefer Gezer, MD
|
|
Give Review
Sefer Gezer is an expert in the field of Hematology. He went to medical school at Wayne State University School of Medicine. Wayne State University School of Medicine has a rank of 63 in research and a 85 in primary care He received awards:"CMS Meaningful Use Stage 1 Certification". Doctor Sefer Gezer, MD is a published doctor and has 27 publications published. The lastest was: 'Incidence of aplastic anemia in Turkey: a hospital-based prospective multicentre study.' Doctor Sefer Gezer, MD is registered with Medicare and accepts Medicare payments.
Publications
- Incidence of aplastic Anemia in Turkey: a hospital-based prospective multicentre study.
- Expression of nucleolar antigen p145 in bone marrow cells of patients with myeloid Leukemias.
- Changes observed in the growth fraction, labeling index, duration of S phase, and total Cell cycle times of HL-60 Cells as they undergo differentiation in response to ...
- Detection of monosomy 7 in interphase cells of patients with Myeloid disorders.
- Remicade as TNF suppressor in patients with myelodysplastic Syndromes.
- Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study.
- Detection of BrdU in the regenerating bone marrow Cells of a patient with AML.
- High remission rate in Acute myeloblastic leukemia with only two days of chemotherapy.
- Acute promyelocytic leukemia (APL) with an unusual cytogenetic presentation.
- A paradigm shift in myelodysplastic Syndromes.
- Novel insights into the biology of myelodysplastic Syndromes: excessive apoptosis and the role of cytokines.
- Biological characteristics of myelodysplastic Syndrome patients who demonstrated high versus no intramedullary apoptosis.
- Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic Syndromes.
- Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic Cell death in the bone marrow of patients with myelodysp...
- Poor prognosis Acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine).
- The clinical and biological effects of thalidomide in patients with myelodysplastic Syndromes.
- Cell cycle kinetic studies in 68 patients with myelodysplastic Syndromes following intravenous iodo- and/or bromodeoxyuridine.
- Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic Syndromes.
- Thalidomide produces transfusion independence in long-standing refractory Anemias of patients with myelodysplastic syndromes.
- Patients with myelodysplastic Syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone.
- Biologic characteristics of patients with hypocellular myelodysplastic Syndromes.
- Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic Syndromes.
- Hematologic genetic testing in high-risk patients before knee arthroplasty: a pilot study.
- Idiopathic hemophagocytic Syndrome with a fulminant clinical course.
- Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic Syndromes patients, particularly in those with high pre-...
- Antiphospholipid syndrome.
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Wayne State University School of Medicine
Hospital
-
Rush University Medical Center -
Rush Oak Park Hospital
Drug Facts
| NPI NUMBER | 1700845153 | |
| NPPES Provider LastName | GEZER | |
| NPPES Provider FirstName | SEFER | |
| NPPES Provider ZIPCode | 606123841 | |
| NPPES Provider State | IL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 177.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700845153 |
| Last Name Of The Provider | GEZER |
| First Name Of The Provider | SEFER |
| View All |
Similar Doctors
|
|
Dr. Helen S. Gue, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah A. Katz, MD |
|
|
Dr. Ratan M. Vohra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leonard A. Kosova, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anaadriana Zakarija, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Reem Karmali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa Boggio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harsha V. Poola, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Santo Saraf, MD
This Doctor is OpenDoctor Recommended.
|